Provexis Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 3

Employees

  • Stock Symbol
  • PXS

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.01
  • (As of Wednesday Closing)

Provexis General Information

Description

Provexis PLC is engaged in developing, licensing, and selling the proprietary, scientifically backed Fruitflow heart-health functional food ingredient for the globally functional food sector. The extract is available in two formats: a syrup and a powder, and it can be included in a broad range of food, beverage, and dietary supplement formats.

Contact Information

Formerly Known As
Nutrinnovator Holdings
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Blagrave Street
  • Berkshire
  • Reading RG1 1AZ
  • England, United Kingdom
+44 07490
Primary Industry
Beverages
Stock Exchange
LON
Vertical(s)
Corporate Office
  • 2 Blagrave Street
  • Berkshire
  • Reading RG1 1AZ
  • England, United Kingdom
+44 07490

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Provexis Stock Performance

As of 18-Nov-2026, Provexis’s stock price is $0.01. Its current market cap is $26.5M with 2.35B shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $26.5M 2.35B 519K

Provexis Financials Summary

As of 31-Mar-2026, Provexis has a trailing 12-month revenue of $1.69M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 31,824 31,824 12,348 16,415
Revenue 1,694 1,694 1,648 1,008
EBITDA (685) (685) (576) (758)
Net Income (674) (674) (577) (737)
Total Assets 1,706 1,706 1,309 629
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Provexis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Provexis‘s full profile, request access.

Request a free trial

Provexis Patents

Provexis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0502985-D0 Therapeutic uses of tomato extracts Inactive 14-Feb-2005
ES-2204130-T3 Anti-thrombosis agents. Inactive 24-Apr-1998
EP-1334728-A2 Antithrombotic agents Inactive 24-Apr-1998
EP-1334728-A3 Antithrombotic agents Inactive 24-Apr-1998 A61K36/81

Provexis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Provexis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Provexis‘s full profile, request access.

Request a free trial

Provexis Acquisitions (2)

Provexis’s most recent deal was a Merger/Acquisition with Science in Sport for . The deal was made on 24-Jun-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Science in Sport 24-Jun-2011 Merger/Acquisition Food Products
Nutrinnovator 01-Jun-2005 Merger/Acquisition Food Products
To view Provexis’s complete acquisitions history, request access »

Provexis ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Provexis’s complete esg history, request access »

Provexis Exits (1)

Provexis’s most recent exit was on 24-Jun-2011 from Science in Sport. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Science in Sport 24-Jun-2011 Completed
To view Provexis’s complete exits history, request access »

Provexis Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Nutrinnovator London, United Kingdom 2002

Provexis FAQs

  • When was Provexis founded?

    Provexis was founded in 1999.

  • Where is Provexis headquartered?

    Provexis is headquartered in Reading, United Kingdom.

  • What is the size of Provexis?

    Provexis has 3 total employees.

  • What industry is Provexis in?

    Provexis’s primary industry is Beverages.

  • Is Provexis a private or public company?

    Provexis is a Public company.

  • What is Provexis’s stock symbol?

    The ticker symbol for Provexis is PXS.

  • What is the current stock price of Provexis?

    As of 18-Nov-2026 the stock price of Provexis is $0.01.

  • What is the current market cap of Provexis?

    The current market capitalization of Provexis is $26.5M.

  • What is Provexis’s current revenue?

    The trailing twelve month revenue for Provexis is $1.69M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process